A transient expansion of the native state precedes aggregation of recombinant human interferon-γ

被引:158
|
作者
Kendrick, BS
Carpenter, JF
Cleland, JL
Randolph, TW
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA
关键词
D O I
10.1073/pnas.95.24.14142
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aggregation of proteins, even under conditions favoring the native state, is a ubiquitous problem in biotechnology and biomedical engineering. Providing a mechanistic basis for the pathways that lead to aggregation should allow development of rational approaches for its prevention. We have chosen recombinant human interferon-gamma (rhIFN-gamma) as a model protein for a mechanistic study of aggregation. In the presence of 0.9 M guanidinium hydrochloride, rhIFN-gamma aggregates with first order kinetics, a process that is inhibited by addition of sucrose. We describe a pathway that accounts for both the observed first-order aggregation of rhIFN-gamma and the effect of sucrose. In this pathway, aggregation proceeds through a transient expansion of the native state. Sucrose shifts the equilibrium within the ensemble of rhIFN-gamma native conformations to favor the most compact native species over more expanded ones, thus stabilizing rhIFN-gamma against aggregation. This phenomenon is attributed to the preferential exclusion of sucrose from the protein surface. In addition, kinetic analysis combined with solution thermodynamics shows that only a small (9%) expansion surface area is needed to form the transient native state that precedes aggregation. The approaches used here link thermodynamics and aggregation kinetics to provide a powerful tool for understanding both the pathway of protein aggregation and the rational use of excipients to inhibit the process.
引用
收藏
页码:14142 / 14146
页数:5
相关论文
共 50 条
  • [31] Process development for production of recombinant human interferon-γ expressed in Escherichia coli
    Khalilzadeh, R
    Shojaosadati, SA
    Maghsoudi, N
    Mohammadian-Mosaabadi, J
    Mohammadi, MR
    Bahrami, A
    Maleksabet, N
    Nassiri-Khalilli, MA
    Ebrahimi, M
    Naderimanesh, H
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2004, 31 (02) : 63 - 69
  • [32] SYNTHESIS OF INTERFERON-αA MONOCLONAL ANTIBODY PACKING MATERIAL IN HIGH-PERFORMANCE AFFINITY CHROMATOGRAPHY AND PURIFICATION OF RECOMBINANT HUMAN INTERFERON-αA
    Wen Ke FENG Xin Du GENG Laboratory of Modern Separation Science
    ChineseChemicalLetters, 1991, (05) : 383 - 386
  • [33] Rational design of glycoengineered interferon-β analogs with improved aggregation state: experimental validation
    Samoudi, M.
    Minuchehr, Z.
    Harcum, S. W.
    Tabandeh, F.
    Yeganeh, N. Omid
    Khodabandeh, M.
    PROTEIN ENGINEERING DESIGN & SELECTION, 2017, 30 (01): : 23 - 30
  • [34] Formation of (timers in refolding of recombinant human interferon-γ by ion-exchange chromatography
    Jin, Ting
    Guan, Yi-Xin
    Yao, Shan-Jing
    Zhejiang Daxue Xuebao (Nongye yu Shengming Kexue Ban)/Journal of the Zhejiang University - Agriculture and Life Science, 2006, 32 (01): : 101 - 105
  • [35] Affinity adsorption of recombinant human interferon-α on a porous dye-affinity adsorbent
    Karakoç, V
    Yavuz, H
    Denizli, A
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2004, 240 (1-3) : 93 - 99
  • [36] Surface adsorption of recombinant human interferon-γ in lyophilized and spray-lyophilized formulations
    Webb, SD
    Golledge, SL
    Cleland, JL
    Carpenter, JF
    Randolph, TW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (06) : 1474 - 1487
  • [37] Effect of recombinant interferon-α2b (Laferon) on human neuroblastoma cells
    V. V. Kucher
    G. Kh. Matsuka
    O. M. Rozhmanova
    E. V. Dolgaya
    L. N. Stelmakh
    N. Kh. Pogorelaya
    Neurophysiology, 2000, 32 : 226 - 227
  • [38] Establishment of transgenic fibroblasts for producing recombinant human interferon-α and erythropoietin in bovine milk
    Jung, Eui-Man
    An, Beum-Soo
    Kim, Yu-Kyung
    Hwang, Inho
    Lee, Jong-Yun
    Shin, Tae-Young
    Hyun, Sang-Hwan
    Hwang, Woo-Suk
    Jeung, Eui-Bae
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 406 - 412
  • [39] Human recombinant interferon-β constructed based on affinity-binding domain technology
    Semikhin, A. S.
    Lyashchuk, A. M.
    Mezentseva, M. V.
    Tregubova, M. I.
    Sergienko, O. V.
    Poletaeva, N. N.
    Naroditskii, B. S.
    Karyagina, A. S.
    Lunin, V. G.
    Gintsburg, A. L.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2009, 24 (04) : 207 - 211
  • [40] Effect of recombinant interferon-α2b (laferon) on human neuroblastoma cells
    Kucher, VV
    Matsuka, GK
    Rozhmanova, OM
    Dolgaya, EV
    Stelmakh, LN
    Pogorelaya, NK
    NEUROPHYSIOLOGY, 2000, 32 (03) : 226 - 227